All investors
Excelerate Health Ventures is a venture capital firm in Durham, NC. It invests at seed to Series A, it backs companies in B2B Software and it leads or co-leads rounds.

Excelerate Health Ventures

Durham, NC
Invests in seed and Series A B2B pharma tech and SaaS companies, then opens doors to pharma, provider, and payer customers.Source
At a glance
Stage
Seed to Series A
Industry
B2B Software
Lead
Leads or co-leads
How to pitch
By email
What they look for
Excelerate Health Ventures invests exclusively in B2B pharma tech and tech-enabled pharma services, backing capital-efficient seed and Series A companies with large addressable markets and defensible moats. It looks for coachable founder teams and connects portfolio companies to pharma, provider, and payer customers through its investor network.
Portfolio highlights
AtalanBEKHealthBivarusCarePort HealthCensinetDiameter HealthDoctivityElligo Health ResearchHealth DecisionsItiliti HealthJumo HealthKorioNurseGridOculus HealthOrbitalRxQoniqRide HealthS2N HealthUSARAD
Latest fund
Fund size
$22M
Their largest fund closed in the last two years, per SEC filings. This is the fund's size, not a check size.
From SEC filings
Board seats2
Doctivity, Inc.
Bloomsburg, PA · Technology
$6M
company round · Q1 2025
Huma.AI, Inc.
Cary, NC · Technology
$1M
company round · Q2 2025
Companies where one of their partners holds a board or officer seat. Typical round: $1M to $5M. Amounts are the company's whole round, not this investor's check.
Named on filings3
Maulik D. Mehta
Executive Officer
Last filed 14 April 2026
B. Bobby Bahram
Executive Officer
Last filed 14 April 2026
Andrew J. Schwab
Executive Officer
Last filed 14 April 2026
Funds
Excelerate Health Ventures III LP
$22M closed from their investors
Q2 2026
2 venture funds in total. Shown here are the ones that filed in the last two years.
Fund filings by quarter
Q3 2024Q2 2026
SourcesLast updated 29 September 2026
Told us whether they lead. Checked 23 September 2026.
Told us their logo, what they invest in and the one-line description above. Checked 23 September 2026.
Told us how they take pitches, the stage they invest at and what they look for. Checked 23 September 2026.
Told us their portfolio. Checked 23 September 2026.
Website
Confirmed as theirs on 22 September 2026.
SEC Form D, 1 filing
Funds, partners and board seats. Filed between 14 April 2026 and 14 April 2026.
SEC Form ADV
Firm name, office and fund count. CRD 312957. Last filed 5 March 2026.